Global Oncolytic Virus Service Market Growth (Status and Outlook) 2026-2032

August 2026 | 105 pages | ID: G6CB45140852EN
LP Information

Abstracts

The global Oncolytic Virus Service market size is predicted to grow from US$ 87450 million in 2025 to US$ 335280 million in 2032; it is expected to grow at a CAGR of 21.6% from 2026 to 2032.

The main contents of oncolytic virus services include virus screening, virus production, quality testing, drug efficacy evaluation, etc. In this process, pharmaceutical companies can select different virus strains and, after appropriate genetic engineering, be used to treat different types of tumors.

With the continuous development of gene editing technology and viral vector technology, more new oncolytic viruses will be developed, providing more options for tumor treatment.

LPI (LP Information)' newest research report, the ?Oncolytic Virus Service Industry Forecast? looks at past sales and reviews total world Oncolytic Virus Service sales in 2025, providing a comprehensive analysis by region and market sector of projected Oncolytic Virus Service sales for 2026 through 2032. With Oncolytic Virus Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Oncolytic Virus Service industry.

This Insight Report provides a comprehensive analysis of the global Oncolytic Virus Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Oncolytic Virus Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Oncolytic Virus Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Oncolytic Virus Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Oncolytic Virus Service.

This report presents a comprehensive overview, market shares, and growth opportunities of Oncolytic Virus Service market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Measles Virus (MeV)
• Herpes Simplex Virus (HSV-1)
• Others

Segmentation by Application:

• Tumor Treatment
• Scientific Research

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Creative Biolabs
• Creative Biogene
• Recipharm
• Nabios
• IDT Biologika
• FUJIFILM Diosynth Biotechnologies
• Exothera
• Lonza
• ABL
• Takara Bio
• Libentech

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Oncolytic Virus Service Market Size (2021-2032)
  2.1.2 Oncolytic Virus Service Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for Oncolytic Virus Service by Country/Region (2021, 2025 & 2032)
2.2 Oncolytic Virus Service Segment by Type
  2.2.1 Measles Virus (MeV)
  2.2.2 Herpes Simplex Virus (HSV-1)
  2.2.3 Others
  2.2.4 Oncolytic Virus Service Market Size by Type
    2.2.4.1 Oncolytic Virus Service Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.4.2 Global Oncolytic Virus Service Market Size Market Share by Type (2021-2026)
2.3 Oncolytic Virus Service Segment by Application
  2.3.1 Tumor Treatment
  2.3.2 Scientific Research
  2.3.3 Oncolytic Virus Service Market Size by Application
    2.3.3.1 Oncolytic Virus Service Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.3.2 Global Oncolytic Virus Service Market Size Market Share by Application (2021-2026)

3 ONCOLYTIC VIRUS SERVICE MARKET SIZE BY PLAYER

3.1 Oncolytic Virus Service Market Size Market Share by Player
  3.1.1 Global Oncolytic Virus Service Revenue by Player (2021-2026)
  3.1.2 Global Oncolytic Virus Service Revenue Market Share by Player (2021-2026)
3.2 Global Oncolytic Virus Service Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 ONCOLYTIC VIRUS SERVICE BY REGION

4.1 Oncolytic Virus Service Market Size by Region (2021-2026)
4.2 Global Oncolytic Virus Service Annual Revenue by Country/Region (2021-2026)
4.3 Americas Oncolytic Virus Service Market Size Growth (2021-2026)
4.4 APAC Oncolytic Virus Service Market Size Growth (2021-2026)
4.5 Europe Oncolytic Virus Service Market Size Growth (2021-2026)
4.6 Middle East & Africa Oncolytic Virus Service Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas Oncolytic Virus Service Market Size by Country (2021-2026)
5.2 Americas Oncolytic Virus Service Market Size by Type (2021-2026)
5.3 Americas Oncolytic Virus Service Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Oncolytic Virus Service Market Size by Region (2021-2026)
6.2 APAC Oncolytic Virus Service Market Size by Type (2021-2026)
6.3 APAC Oncolytic Virus Service Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Oncolytic Virus Service Market Size by Country (2021-2026)
7.2 Europe Oncolytic Virus Service Market Size by Type (2021-2026)
7.3 Europe Oncolytic Virus Service Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Oncolytic Virus Service by Region (2021-2026)
8.2 Middle East & Africa Oncolytic Virus Service Market Size by Type (2021-2026)
8.3 Middle East & Africa Oncolytic Virus Service Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL ONCOLYTIC VIRUS SERVICE MARKET FORECAST

10.1 Global Oncolytic Virus Service Forecast by Region (2027-2032)
  10.1.1 Global Oncolytic Virus Service Forecast by Region (2027-2032)
  10.1.2 Americas Oncolytic Virus Service Forecast
  10.1.3 APAC Oncolytic Virus Service Forecast
  10.1.4 Europe Oncolytic Virus Service Forecast
  10.1.5 Middle East & Africa Oncolytic Virus Service Forecast
10.2 Americas Oncolytic Virus Service Forecast by Country (2027-2032)
  10.2.1 United States Market Oncolytic Virus Service Forecast
  10.2.2 Canada Market Oncolytic Virus Service Forecast
  10.2.3 Mexico Market Oncolytic Virus Service Forecast
  10.2.4 Brazil Market Oncolytic Virus Service Forecast
10.3 APAC Oncolytic Virus Service Forecast by Region (2027-2032)
  10.3.1 China Oncolytic Virus Service Market Forecast
  10.3.2 Japan Market Oncolytic Virus Service Forecast
  10.3.3 Korea Market Oncolytic Virus Service Forecast
  10.3.4 Southeast Asia Market Oncolytic Virus Service Forecast
  10.3.5 India Market Oncolytic Virus Service Forecast
  10.3.6 Australia Market Oncolytic Virus Service Forecast
10.4 Europe Oncolytic Virus Service Forecast by Country (2027-2032)
  10.4.1 Germany Market Oncolytic Virus Service Forecast
  10.4.2 France Market Oncolytic Virus Service Forecast
  10.4.3 UK Market Oncolytic Virus Service Forecast
  10.4.4 Italy Market Oncolytic Virus Service Forecast
  10.4.5 Russia Market Oncolytic Virus Service Forecast
10.5 Middle East & Africa Oncolytic Virus Service Forecast by Region (2027-2032)
  10.5.1 Egypt Market Oncolytic Virus Service Forecast
  10.5.2 South Africa Market Oncolytic Virus Service Forecast
  10.5.3 Israel Market Oncolytic Virus Service Forecast
  10.5.4 Turkey Market Oncolytic Virus Service Forecast
10.6 Global Oncolytic Virus Service Forecast by Type (2027-2032)
10.7 Global Oncolytic Virus Service Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market Oncolytic Virus Service Forecast

11 KEY PLAYERS ANALYSIS

11.1 Creative Biolabs
  11.1.1 Creative Biolabs Company Information
  11.1.2 Creative Biolabs Oncolytic Virus Service Product Offered
  11.1.3 Creative Biolabs Oncolytic Virus Service Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Creative Biolabs Main Business Overview
  11.1.5 Creative Biolabs Latest Developments
11.2 Creative Biogene
  11.2.1 Creative Biogene Company Information
  11.2.2 Creative Biogene Oncolytic Virus Service Product Offered
  11.2.3 Creative Biogene Oncolytic Virus Service Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 Creative Biogene Main Business Overview
  11.2.5 Creative Biogene Latest Developments
11.3 Recipharm
  11.3.1 Recipharm Company Information
  11.3.2 Recipharm Oncolytic Virus Service Product Offered
  11.3.3 Recipharm Oncolytic Virus Service Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 Recipharm Main Business Overview
  11.3.5 Recipharm Latest Developments
11.4 Nabios
  11.4.1 Nabios Company Information
  11.4.2 Nabios Oncolytic Virus Service Product Offered
  11.4.3 Nabios Oncolytic Virus Service Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Nabios Main Business Overview
  11.4.5 Nabios Latest Developments
11.5 IDT Biologika
  11.5.1 IDT Biologika Company Information
  11.5.2 IDT Biologika Oncolytic Virus Service Product Offered
  11.5.3 IDT Biologika Oncolytic Virus Service Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 IDT Biologika Main Business Overview
  11.5.5 IDT Biologika Latest Developments
11.6 FUJIFILM Diosynth Biotechnologies
  11.6.1 FUJIFILM Diosynth Biotechnologies Company Information
  11.6.2 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Product Offered
  11.6.3 FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Revenue, Gross Margin and Market Share (2021-2026)
  11.6.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
  11.6.5 FUJIFILM Diosynth Biotechnologies Latest Developments
11.7 Exothera
  11.7.1 Exothera Company Information
  11.7.2 Exothera Oncolytic Virus Service Product Offered
  11.7.3 Exothera Oncolytic Virus Service Revenue, Gross Margin and Market Share (2021-2026)
  11.7.4 Exothera Main Business Overview
  11.7.5 Exothera Latest Developments
11.8 Lonza
  11.8.1 Lonza Company Information
  11.8.2 Lonza Oncolytic Virus Service Product Offered
  11.8.3 Lonza Oncolytic Virus Service Revenue, Gross Margin and Market Share (2021-2026)
  11.8.4 Lonza Main Business Overview
  11.8.5 Lonza Latest Developments
11.9 ABL
  11.9.1 ABL Company Information
  11.9.2 ABL Oncolytic Virus Service Product Offered
  11.9.3 ABL Oncolytic Virus Service Revenue, Gross Margin and Market Share (2021-2026)
  11.9.4 ABL Main Business Overview
  11.9.5 ABL Latest Developments
11.10 Takara Bio
  11.10.1 Takara Bio Company Information
  11.10.2 Takara Bio Oncolytic Virus Service Product Offered
  11.10.3 Takara Bio Oncolytic Virus Service Revenue, Gross Margin and Market Share (2021-2026)
  11.10.4 Takara Bio Main Business Overview
  11.10.5 Takara Bio Latest Developments
11.11 Libentech
  11.11.1 Libentech Company Information
  11.11.2 Libentech Oncolytic Virus Service Product Offered
  11.11.3 Libentech Oncolytic Virus Service Revenue, Gross Margin and Market Share (2021-2026)
  11.11.4 Libentech Main Business Overview
  11.11.5 Libentech Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Oncolytic Virus Service Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Oncolytic Virus Service Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Measles Virus (MeV)
Table 4. Major Players of Herpes Simplex Virus (HSV-1)
Table 5. Major Players of Others
Table 6. Oncolytic Virus Service Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 7. Global Oncolytic Virus Service Market Size by Type (2021-2026) & ($ millions)
Table 8. Global Oncolytic Virus Service Market Size Market Share by Type (2021-2026)
Table 9. Oncolytic Virus Service Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 10. Global Oncolytic Virus Service Market Size by Application (2021-2026) & ($ millions)
Table 11. Global Oncolytic Virus Service Market Size Market Share by Application (2021-2026)
Table 12. Global Oncolytic Virus Service Revenue by Player (2021-2026) & ($ millions)
Table 13. Global Oncolytic Virus Service Revenue Market Share by Player (2021-2026)
Table 14. Oncolytic Virus Service Key Players Head office and Products Offered
Table 15. Oncolytic Virus Service Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Oncolytic Virus Service Market Size by Region (2021-2026) & ($ millions)
Table 19. Global Oncolytic Virus Service Market Size Market Share by Region (2021-2026)
Table 20. Global Oncolytic Virus Service Revenue by Country/Region (2021-2026) & ($ millions)
Table 21. Global Oncolytic Virus Service Revenue Market Share by Country/Region (2021-2026)
Table 22. Americas Oncolytic Virus Service Market Size by Country (2021-2026) & ($ millions)
Table 23. Americas Oncolytic Virus Service Market Size Market Share by Country (2021-2026)
Table 24. Americas Oncolytic Virus Service Market Size by Type (2021-2026) & ($ millions)
Table 25. Americas Oncolytic Virus Service Market Size Market Share by Type (2021-2026)
Table 26. Americas Oncolytic Virus Service Market Size by Application (2021-2026) & ($ millions)
Table 27. Americas Oncolytic Virus Service Market Size Market Share by Application (2021-2026)
Table 28. APAC Oncolytic Virus Service Market Size by Region (2021-2026) & ($ millions)
Table 29. APAC Oncolytic Virus Service Market Size Market Share by Region (2021-2026)
Table 30. APAC Oncolytic Virus Service Market Size by Type (2021-2026) & ($ millions)
Table 31. APAC Oncolytic Virus Service Market Size by Application (2021-2026) & ($ millions)
Table 32. Europe Oncolytic Virus Service Market Size by Country (2021-2026) & ($ millions)
Table 33. Europe Oncolytic Virus Service Market Size Market Share by Country (2021-2026)
Table 34. Europe Oncolytic Virus Service Market Size by Type (2021-2026) & ($ millions)
Table 35. Europe Oncolytic Virus Service Market Size by Application (2021-2026) & ($ millions)
Table 36. Middle East & Africa Oncolytic Virus Service Market Size by Region (2021-2026) & ($ millions)
Table 37. Middle East & Africa Oncolytic Virus Service Market Size by Type (2021-2026) & ($ millions)
Table 38. Middle East & Africa Oncolytic Virus Service Market Size by Application (2021-2026) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Oncolytic Virus Service
Table 40. Key Market Challenges & Risks of Oncolytic Virus Service
Table 41. Key Industry Trends of Oncolytic Virus Service
Table 42. Global Oncolytic Virus Service Market Size Forecast by Region (2027-2032) & ($ millions)
Table 43. Global Oncolytic Virus Service Market Size Market Share Forecast by Region (2027-2032)
Table 44. Global Oncolytic Virus Service Market Size Forecast by Type (2027-2032) & ($ millions)
Table 45. Global Oncolytic Virus Service Market Size Forecast by Application (2027-2032) & ($ millions)
Table 46. Creative Biolabs Details, Company Type, Oncolytic Virus Service Area Served and Its Competitors
Table 47. Creative Biolabs Oncolytic Virus Service Product Offered
Table 48. Creative Biolabs Oncolytic Virus Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 49. Creative Biolabs Main Business
Table 50. Creative Biolabs Latest Developments
Table 51. Creative Biogene Details, Company Type, Oncolytic Virus Service Area Served and Its Competitors
Table 52. Creative Biogene Oncolytic Virus Service Product Offered
Table 53. Creative Biogene Oncolytic Virus Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 54. Creative Biogene Main Business
Table 55. Creative Biogene Latest Developments
Table 56. Recipharm Details, Company Type, Oncolytic Virus Service Area Served and Its Competitors
Table 57. Recipharm Oncolytic Virus Service Product Offered
Table 58. Recipharm Oncolytic Virus Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 59. Recipharm Main Business
Table 60. Recipharm Latest Developments
Table 61. Nabios Details, Company Type, Oncolytic Virus Service Area Served and Its Competitors
Table 62. Nabios Oncolytic Virus Service Product Offered
Table 63. Nabios Oncolytic Virus Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 64. Nabios Main Business
Table 65. Nabios Latest Developments
Table 66. IDT Biologika Details, Company Type, Oncolytic Virus Service Area Served and Its Competitors
Table 67. IDT Biologika Oncolytic Virus Service Product Offered
Table 68. IDT Biologika Oncolytic Virus Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 69. IDT Biologika Main Business
Table 70. IDT Biologika Latest Developments
Table 71. FUJIFILM Diosynth Biotechnologies Details, Company Type, Oncolytic Virus Service Area Served and Its Competitors
Table 72. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Product Offered
Table 73. FUJIFILM Diosynth Biotechnologies Oncolytic Virus Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 74. FUJIFILM Diosynth Biotechnologies Main Business
Table 75. FUJIFILM Diosynth Biotechnologies Latest Developments
Table 76. Exothera Details, Company Type, Oncolytic Virus Service Area Served and Its Competitors
Table 77. Exothera Oncolytic Virus Service Product Offered
Table 78. Exothera Oncolytic Virus Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 79. Exothera Main Business
Table 80. Exothera Latest Developments
Table 81. Lonza Details, Company Type, Oncolytic Virus Service Area Served and Its Competitors
Table 82. Lonza Oncolytic Virus Service Product Offered
Table 83. Lonza Oncolytic Virus Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 84. Lonza Main Business
Table 85. Lonza Latest Developments
Table 86. ABL Details, Company Type, Oncolytic Virus Service Area Served and Its Competitors
Table 87. ABL Oncolytic Virus Service Product Offered
Table 88. ABL Oncolytic Virus Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 89. ABL Main Business
Table 90. ABL Latest Developments
Table 91. Takara Bio Details, Company Type, Oncolytic Virus Service Area Served and Its Competitors
Table 92. Takara Bio Oncolytic Virus Service Product Offered
Table 93. Takara Bio Oncolytic Virus Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 94. Takara Bio Main Business
Table 95. Takara Bio Latest Developments
Table 96. Libentech Details, Company Type, Oncolytic Virus Service Area Served and Its Competitors
Table 97. Libentech Oncolytic Virus Service Product Offered
Table 98. Libentech Oncolytic Virus Service Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 99. Libentech Main Business
Table 100. Libentech Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Oncolytic Virus Service Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncolytic Virus Service Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Oncolytic Virus Service Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Oncolytic Virus Service Sales Market Share by Country/Region (2025)
Figure 8. Oncolytic Virus Service Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Oncolytic Virus Service Market Size Market Share by Type in 2025
Figure 10. Oncolytic Virus Service in Tumor Treatment
Figure 11. Global Oncolytic Virus Service Market: Tumor Treatment (2021-2026) & ($ millions)
Figure 12. Oncolytic Virus Service in Scientific Research
Figure 13. Global Oncolytic Virus Service Market: Scientific Research (2021-2026) & ($ millions)
Figure 14. Global Oncolytic Virus Service Market Size Market Share by Application in 2025
Figure 15. Global Oncolytic Virus Service Revenue Market Share by Player in 2025
Figure 16. Global Oncolytic Virus Service Market Size Market Share by Region (2021-2026)
Figure 17. Americas Oncolytic Virus Service Market Size 2021-2026 ($ millions)
Figure 18. APAC Oncolytic Virus Service Market Size 2021-2026 ($ millions)
Figure 19. Europe Oncolytic Virus Service Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Oncolytic Virus Service Market Size 2021-2026 ($ millions)
Figure 21. Americas Oncolytic Virus Service Value Market Share by Country in 2025
Figure 22. United States Oncolytic Virus Service Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Oncolytic Virus Service Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Oncolytic Virus Service Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Oncolytic Virus Service Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Oncolytic Virus Service Market Size Market Share by Region in 2025
Figure 27. APAC Oncolytic Virus Service Market Size Market Share by Type (2021-2026)
Figure 28. APAC Oncolytic Virus Service Market Size Market Share by Application (2021-2026)
Figure 29. China Oncolytic Virus Service Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Oncolytic Virus Service Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Oncolytic Virus Service Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Oncolytic Virus Service Market Size Growth 2021-2026 ($ millions)
Figure 33. India Oncolytic Virus Service Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Oncolytic Virus Service Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Oncolytic Virus Service Market Size Market Share by Country in 2025
Figure 36. Europe Oncolytic Virus Service Market Size Market Share by Type (2021-2026)
Figure 37. Europe Oncolytic Virus Service Market Size Market Share by Application (2021-2026)
Figure 38. Germany Oncolytic Virus Service Market Size Growth 2021-2026 ($ millions)
Figure 39. France Oncolytic Virus Service Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Oncolytic Virus Service Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Oncolytic Virus Service Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Oncolytic Virus Service Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Oncolytic Virus Service Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Oncolytic Virus Service Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Oncolytic Virus Service Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Oncolytic Virus Service Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Oncolytic Virus Service Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Oncolytic Virus Service Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Oncolytic Virus Service Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Oncolytic Virus Service Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Oncolytic Virus Service Market Size 2027-2032 ($ millions)
Figure 52. APAC Oncolytic Virus Service Market Size 2027-2032 ($ millions)
Figure 53. Europe Oncolytic Virus Service Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Oncolytic Virus Service Market Size 2027-2032 ($ millions)
Figure 55. United States Oncolytic Virus Service Market Size 2027-2032 ($ millions)
Figure 56. Canada Oncolytic Virus Service Market Size 2027-2032 ($ millions)
Figure 57. Mexico Oncolytic Virus Service Market Size 2027-2032 ($ millions)
Figure 58. Brazil Oncolytic Virus Service Market Size 2027-2032 ($ millions)
Figure 59. China Oncolytic Virus Service Market Size 2027-2032 ($ millions)
Figure 60. Japan Oncolytic Virus Service Market Size 2027-2032 ($ millions)
Figure 61. Korea Oncolytic Virus Service Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Oncolytic Virus Service Market Size 2027-2032 ($ millions)
Figure 63. India Oncolytic Virus Service Market Size 2027-2032 ($ millions)
Figure 64. Australia Oncolytic Virus Service Market Size 2027-2032 ($ millions)
Figure 65. Germany Oncolytic Virus Service Market Size 2027-2032 ($ millions)
Figure 66. France Oncolytic Virus Service Market Size 2027-2032 ($ millions)
Figure 67. UK Oncolytic Virus Service Market Size 2027-2032 ($ millions)
Figure 68. Italy Oncolytic Virus Service Market Size 2027-2032 ($ millions)
Figure 69. Russia Oncolytic Virus Service Market Size 2027-2032 ($ millions)
Figure 70. Egypt Oncolytic Virus Service Market Size 2027-2032 ($ millions)
Figure 71. South Africa Oncolytic Virus Service Market Size 2027-2032 ($ millions)
Figure 72. Israel Oncolytic Virus Service Market Size 2027-2032 ($ millions)
Figure 73. Turkey Oncolytic Virus Service Market Size 2027-2032 ($ millions)
Figure 74. Global Oncolytic Virus Service Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Oncolytic Virus Service Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Oncolytic Virus Service Market Size 2027-2032 ($ millions)